Blood pressure drug could become unexpected weapon against MRSA superbug

deepseek / deepseek-v4-flash

2026-05-07 12:26

Science Scientific Discovery

Article in German Article in Croatian

Teksas SAD

The blood pressure drug candesartan cilexetil (CC) shows potential in fighting MRSA, an antibiotic-resistant bacterium.
Research published in Nature Communications shows that CC disrupts the bacterial membrane and leads to bacterial destruction.
In laboratory and animal experiments, the drug reduced bacterial load and enhanced the effect of antibiotics like gentamicin.
MRSA causes over 70,000 severe infections and 9,000 deaths annually in the US.
Scientists are developing chemical variants of CC to increase efficacy and reduce side effects, and are seeking partnerships with pharmaceutical companies.